PharmaCielo Ltd.
PCLOF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $13,142 | $27,329 | $24,533 | $142,859 |
| - Cash | $148 | $62 | $173 | $5,338 |
| + Debt | $20,524 | $18,309 | $12,587 | $8,430 |
| Enterprise Value | $33,518 | $45,575 | $36,948 | $145,951 |
| Revenue | $3,480 | $1,542 | $5,309 | $1,945 |
| % Growth | 125.7% | -71% | 172.9% | – |
| Gross Profit | $731 | -$1,369 | $681 | -$4,308 |
| % Margin | 21% | -88.8% | 12.8% | -221.5% |
| EBITDA | -$4,603 | -$12,189 | -$10,501 | -$24,840 |
| % Margin | -132.3% | -790.6% | -197.8% | -1,277.1% |
| Net Income | -$9,141 | -$16,298 | -$14,516 | -$26,630 |
| % Margin | -262.7% | -1,057.1% | -273.5% | -1,369.1% |
| EPS Diluted | -0.052 | -0.1 | -0.096 | -0.18 |
| % Growth | 47.8% | -4.1% | 46.6% | – |
| Operating Cash Flow | -$1,969 | -$5,150 | -$9,875 | -$20,073 |
| Capital Expenditures | $0 | -$15 | -$522 | -$1,138 |
| Free Cash Flow | -$1,969 | -$5,165 | -$10,397 | -$21,211 |